A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles
Drug Design, Development and Therapy · 2024-02 · Volume 18 · 613-630
DOI: 10.2147/dddt.s439975 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Design, Development and Therapy, 2024-02. Verfasst von Hilda Amekyeh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, University of Health and Allied Sciences, Ho, Ghana. Hauptthemen laut MEDLINE: Nanoparticles. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, University of Health and Allied Sciences, Ho, Ghana.
- Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, USA.
- College of Pharmacy, Qatar University, Doha, Qatar.
ORCID-Profile: Hilda Amekyeh, Nashiru Billa
Zitieren
APA
Amekyeh, H., Sabra, R., & Billa, N. (2024). A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles. Drug Design, Development and Therapy, Volume 18, 613-630. https://doi.org/10.2147/dddt.s439975
Vancouver
Amekyeh H, Sabra R, Billa N. A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles. Drug Design, Development and Therapy. 2024;Volume 18:613-630. doi:10.2147/dddt.s439975
BibTeX
@article{Amekyeh2024,
author = {Amekyeh, Hilda and Sabra, Rayan and Billa, Nashiru},
title = {A Window for Enhanced Oral Delivery of Therapeutics via Lipid Nanoparticles},
journal = {Drug Design, Development and Therapy},
year = {2024},
volume = {Volume 18},
pages = {613--630},
doi = {10.2147/dddt.s439975}
}
EUVIMED